CurveBeam AIASX:CVB Gross Margin % is 36.78% as of Dec. 2025, which is 20% below its 10-year median of 46.07. The stock has 5 warning signs investors should review. Among 805 Medical Devices & Instruments companies, CurveBeam AI ranks worse than 66.21% on this metric.
The historical rank and industry rank for CurveBeam AI's Gross Margin % or its related term are showing as below:
ASX:CVB'
s Gross Margin % Range Over the Past 10 Years
Min: 41.75 Med: 46.07 Max: 54.54
Current: 41.75
During the past 5 years, the highestGross Margin % of CurveBeam AI was 54.54%. The lowest was 41.75%. And the median was 46.07%.
ASX:CVB's Gross Margin % is ranked worse than 66.21% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs ASX:CVB: 41.75
CurveBeam AI had a gross margin of 36.78% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for CurveBeam AI was 0.00% per year.
CurveBeam AI (ASX:CVB) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
CurveBeam AI had a gross margin of 36.78% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
CurveBeam AI Gross Margin % Related Terms
CurveBeam AI Gross Margin % Historical Data
* Premium members only.
The historical data trend for CurveBeam AI's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:CVB vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, CurveBeam AI's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CurveBeam AI Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's Gross Margin % distribution charts can be found below:
* The bar in red indicates where CurveBeam AI's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
CurveBeam AI (ASX:CVB) has a Gross Margin % of 36.78% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on CurveBeam AI and its competitors. This is 20% below median its historical median of 46.07. Over the past decade, CurveBeam AI's Gross Margin % has ranged from 41.75 to 54.54. According to the industry distribution chart, CurveBeam AI ranks #533 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 66.2%.
Is CurveBeam AI's Gross Margin % too high?
CurveBeam AI's current Gross Margin % of 36.78% is 20% below median its 10-year median of 46.07. Over the past 10 years, this metric has ranged from a low of 41.75 to a high of 54.54. The Medical Devices & Instruments industry median Gross Margin % is 52.07. CurveBeam AI's value of 36.78% is 29.4% below this industry median. Based on the distribution chart, CurveBeam AI ranks #533 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does CurveBeam AI's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CurveBeam AI ranks #533 out of 805 companies for Gross Margin %. This places CurveBeam AI in the lower half of its industry. The industry median Gross Margin % is 52.07. CurveBeam AI's value of 36.78% is 29.4% below this benchmark. Historically, CurveBeam AI's own Gross Margin % has ranged from 41.75 to 54.54 over the past decade. While the company's 10-year median is 46.07 vs. the industry median of 52.07, CurveBeam AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CurveBeam AI's current Gross Margin % of 36.78% is 29.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on CurveBeam AI and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CurveBeam AI's current Gross Margin % is 36.78%, which is 20% below median its own 10-year median of 46.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CurveBeam AI stock overvalued right now?
CurveBeam AI (ASX:CVB) has a current Gross Margin % of 36.78%. The current Gross Margin % is 36.78%, which is 20% below median its 10-year median of 46.07 and 29.4% below the Medical Devices & Instruments industry median of 52.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For CurveBeam AI (ASX:CVB), the current Gross Margin % is 36.78% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CVB has been successfully added to your 